April 03, 2019
Swiss pharmaceutical company Roche Holding AG escaped, for the second time, a proposed class action accusing it and four executives of misleading investors about the results of a breast cancer study after a New Jersey federal judge dismissed the suit Wednesday.
September 25, 2018
Roche Holding AG has knocked down a putative securities class action after a New Jersey federal judge concluded that the pharmaceutical giant and its executives did not make false or misleading statements about the results of a breast cancer treatment study.
June 07, 2017
Roche was hit with a potential shareholder class action in New Jersey federal court on Tuesday, alleging that the drugmaker misrepresented to investors the effectiveness of a breast cancer treatment under development.